Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 32.52 | N/A |
| PEG Ratio (TTM) | 1.04 | N/A |
| P/S Ratio (TTM) | 0.67 | N/A |
| P/B Ratio (TTM) | 1.22 | N/A |
| P/FCF Ratio (TTM) | 12.65 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.46 | N/A |
| Price to 5YR AVG FCF Ratio | -58.11 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.90% | N/A |
| ROE (TTM) | 3.79% | N/A |
| Net Profit Margin (TTM) | 2.10% | N/A |
| ROIC 5YR AVG | 6.41% | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 317.73% | 7.86% | -8.30% |
| Revenue | -0.64% | 6.43% | 4.27% |
| Net Income | 317.88% | 7.70% | -8.56% |
| Cash Flow | -23.34% | -11.34% | 19.53% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.27 | N/A |
| Quick Ratio (TTM) | 0.86 | N/A |
| D/E Ratio (TTM) | 0.56 | N/A |
| Interest Coverage (TTM) | 12.06 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.57 | N/A |
| LTL to 5YR AVG FCF | -18.18 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.21% | N/A |